A detailed history of O'Keefe Stevens Advisory, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, O'Keefe Stevens Advisory, Inc. holds 64,868 shares of PFE stock, worth $1.72 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
64,868
Previous 52,301 24.03%
Holding current value
$1.72 Million
Previous $1.46 Million 28.3%
% of portfolio
0.61%
Previous 0.53%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$27.7 - $31.39 $348,105 - $394,478
12,567 Added 24.03%
64,868 $1.88 Million
Q2 2024

Jul 10, 2024

BUY
$25.26 - $29.6 $675,048 - $791,030
26,724 Added 104.48%
52,301 $1.46 Million
Q1 2024

Apr 11, 2024

BUY
$25.89 - $29.73 $262,602 - $301,551
10,143 Added 65.72%
25,577 $709,000
Q4 2023

Jan 05, 2024

BUY
$26.13 - $33.94 $170,263 - $221,153
6,516 Added 73.07%
15,434 $444,000
Q3 2023

Oct 18, 2023

BUY
$32.09 - $37.51 $26,089 - $30,495
813 Added 10.03%
8,918 $295,000
Q2 2023

Jul 06, 2023

BUY
$36.12 - $41.79 $42,766 - $49,479
1,184 Added 17.11%
8,105 $297,000
Q1 2023

Apr 11, 2023

BUY
$39.39 - $51.28 $33,323 - $43,382
846 Added 13.93%
6,921 $282,000
Q1 2022

Apr 13, 2022

SELL
$45.75 - $56.69 $4,575 - $5,669
-100 Reduced 1.62%
6,075 $315,000
Q2 2018

Jul 08, 2019

SELL
$32.98 - $35.16 $4,946 - $5,273
-150 Reduced 2.37%
6,175 $224,000
Q1 2018

Jul 08, 2019

BUY
$31.91 - $37.02 $19,146 - $22,212
600 Added 10.48%
6,325 $224,000
Q4 2017

Jul 08, 2019

BUY
$33.26 - $35.29 $190,413 - $202,035
5,725
5,725 $207,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track O'Keefe Stevens Advisory, Inc. Portfolio

Follow O'Keefe Stevens Advisory, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Keefe Stevens Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on O'Keefe Stevens Advisory, Inc. with notifications on news.